Blood substitutes: Old problems, new solutions?;Les substituts de globules rouges: Nouvelles solutions pour de vieux problemes

Hematologie

Volumn 4, Issue 4, 1998, Pages 267-276

  Winslow, Robert M ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Blood substitutes; Oxygen transport; Pathophysiology; Secondary effects

Indexed keywords

BLOOD SUBSTITUTION; HEMOGLOBIN DETERMINATION; HUMAN; OXYGEN AFFINITY; OXYGEN SATURATION; OXYGEN TRANSPORT; REVIEW;

EID: 0031761243     PISSN: 12647527     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Winslow RM Hemoglobin-based red cell substitutes. Baltimore : Johns Hopkins University Press, 1992
2. Hess JR, Riess RF. Resuscitation and the limited utility of the present generation of blood substitutes. Transf Med Rev 1996 ; 10 : 276-85.
3. Rudolph AS. Encapsulation of hemoglobin in liposomes In : Winslow RM, Vandegriff KD, Intaglietta M, eds. Blood substitutes physiological basis of efficacy. Boston Birkhäuser, 1995 : 90-104.
4. Iwasaki K, Iwashita Y. Preparation and evaluation of hemoglobin-polyethylene glycol conjugate (pyridoxalated polyethylene glycol hemoglobin) as an oxygen-carrying resuscitation fluid. Artif Organs 1986 ; 10 411-6
5. Dellacherie E, Bonneaux F, Labrude P, Vigneron C. Modification of human hemoglobin by covalent association with soluble dextran. Biochim Biophys Acta 1983 ; 749 : 106-14.
6. Tam S, Blumenstein H, Wong JTE. Blood replacement in dogs by dextran-hemoglobin Can J Biochem 1978 ; 56 : 981-4.
7. Chatterjee R, Welty EV, Walder RY, Pruitt SL, Rogers PH, Arnone A, Walder JA. Isolation and characterization of a new hemoglobin derivative crosslinked between α chains (Lysine 99α 1-Lysine 99α 2). J Biol Chem 1986 ; 261 : 9929-37
8. Hess JR, MacDonald VW, Brinkley WW. Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin. J Appl Physiol 1993 ; 74 : 1769-78
9. Hoffman SJ, Looker DL, Roehrich JM, Cozart PE, Durfee SL, Tedesco JL, Stetler GL. Expression of fully functional tetrameric human hemoglobin in Escherichia coli. Proc Nat Acad Sci USA 1990 , 87 : 8521-5.
10. Looker D, Abbott-Brown D, Cozart P, Durfee S, Hoffman S, Mathews AJ, Miller-Roehrich J, Shoemaker S, Trimble S, Fermi G, Komiyama NH, Nagai K, Stetler GL A human recombinant haemoglobin designed for use as a blood substitute Nature 1992 ; 356 258-60.
11. Murray JA, Ledlow A, Launspach J, Evans D, Loveday M, Concklin JL. The effects of recombinant human hemoglobin on esophageal motor function in humans Gastroenterology 1995 ; 109 . 1241-8.
12. Gould SA, Sehgal LR, Sehgal HL, Moss GS. The development of hemoglobin solutions as red cell substitutes : hemoglobin solutions Transfus Sci 1995 ; 16 : 5-17.
13. Hsia JC. Pasteurizable, freeze-driable hemoglobin-based blood substitute. U S Patent Number 1989 ; Aug 15 : 4.857.636.
14. Lee R, Atsumi N, Jacobs EE, Austen WG, Vlahakes GJ. Ultrapure, stroma-free, polymerized bovine hemoglobin solution : evaluation of renal toxicity. J Surg Res G 1989 ; 47 : 407-11
15. Hughes GS, Francom SF, Antal EJ, Adams WJ, Locker PK, Yancey EP, Jacobs EE. Hematologic effects of a novel hemoglobin-based oxygen carrier in normal male and female subjects. J Lab Clin Med 1995 ; 126 : 441-51
16. Kasper SM, Walter M, Grune F, Bischoff A, Erasmi H, Buzello W. Effects of a hemoglobin-based oxygen carrier (HBOC-201) on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery Cardiovasc Anesth 1996 ; 83 : 921-7.
17. Flaim SF, Perflubron-based emulsion efficacy as temporary oxygen carrier. In Winslow RM, Vandegriff KD, Intaglietta M, eds. Advances in blood substitutes : industrial opportunities and medical challenges Boston : Birkhäuser, 1997 : 91-132.
18. Kaufman RJ. Clinical development of perfluorocarbon-based red cell substitutes. In : Winslow RM, Vandegriff KD, Intaglietta M, eds. Advances in blood substitutes : industrial opportunities and medical challenges. Boston : Birkhäuser, 1997 : 53-75.
19. Center for Biologics Evaluation and Research. Points to consider in the safety and evaluation of hemoglobin-based oxygen carriers. Transfusion 1991 ; 31 369-71
20. Center for Biologics Evaluation and Research. Points to consider on efficacy evaluation of hemoglobin- and perfluorocarbon-based oxygen carriers. Transfusion 1994 ; 34 : 712-3.
21. Fratantoni J Demonstration of the efficacy of a therapeutic agent. In Winslow RM, Vandegriff KD, Intaglietta M, eds Advances in blood substitutes : industrial opportunities and medical challenges. Boston : Birkäuser, 1997 : 20-4.
22. Hess JR, Riess RF. Resuscitation and the limited utility of the present generation of blood substitutes. Transfus Med Rev 1996 ; 10 . 276-85.
23. Przybelski RJ, Daily EK, Birnbaum ML. The pressor effect of hemoglobin good or bad. In . Winslow RM, Vandegriff KD, Intaglietta M, eds. Advances in blood substitutes: industrial opportunities and medical challenges. Boston : Birkhäuser, 1997 : 71-90.
24. Hager S, Gonzales A, Gonzales M, Winslow RM. Erythropoietin response to blood substitutes. a model for tissue hypoxia. Blood 1996 , 88 : 184a.
25. Suit H. Tumor oxygenation and radiosensitivity In : Winslow RM, Vandegriff KD, Intaglietta M, eds. Advances in blood substitutes : industrial opportunities and medical challenges. Boston : Birkhäuser, 1997 : 187-99
26. Federspiel WJ, Popel AS. A theoretical analysis of the effect of the particulate nature of blood on oxygen release in capillaries Microvasc Res 1986 , 32 : 164-89.
27. Homer LD, Weathersby PK, Kiesow LA. Oxygen gradients between red blood cells in the microciculation. Microvasc Res 1996 , 22 : 308-23
28. Intaglietta M, Johnson PC, Winslow RM Microvascular and tissue oxygen distribution Cardiovasc Res 1996 , 32 . 632-43.
29. 2 uptake of working in situ dog muscle. Adv Exp Med Biol 1994 ; 361 : 375-8.
30. Biro GP, Anderson PJ, Curtis SE, Cain SM. Stroma-free hemoglobin its presence in plasma does not improve oxygen supply to the resting hindlimb vascular bed of hemodiluted dogs. Can J Physiol Pharmacol 1991 , 69 : 1656-62
31. 2 uptake of in situ dog muscle working maximally. J Appl Physiol 1992 , 361 . 2470-5
32. Furchgott RF, Martin W, Cherry PD Blockade of endothelium-dependent vasodilation by hemoglobin : a possible factor in vasospasm associated with hemorrhage. Adv Prostaglandin Thromboxane Leukotnene Res 1985 ; 15 . 499-502.
33. Lemon DD, Doherty DH, Curry SR, Mathews AJ, Doyle MP, Fattor TJ, Olson JS. Control of the nitric oxide-scavenging activity of hemoglobin. Art Cells, Blood Subst, Immob Biotech 1996 ; 24 : 378.
34. Jia L, Bonaventura J, Stamler JS. S-nitrosohaemoglobin : a dynamic activity of blood involved in vascular control (see comments) Nature 1996 , 380 : 2219-6.
35. Rohlfs RJ, Bruner E, Chiu A, Gonzales A, Magde D, Magde MD, Vandegriff KD, Winslow RM. Arterial blood pressure responses to cell-free hemoglobin solutions and the reaction with nitric oxide. J Biol Chem 1998 ; 273 : 12128-34.
36. 2 measurement by phosphorescence decay method Am J Physiol 1993 , 265 H1434-8.
37. Saltzman D, Delano FA, Schmid-Schönbein GW. The microvasculature in skeletal muscle. VI. Adrenergic innervation of arterioles in normotensive and spontaneously hypertensive rats. Microvasc Res 1992 ; 44 : 263-73.
38. Vaughan P Creutzfeldt-Jakob disease latest unknown in struggle to restore faith in blood supply. Can Med J 1996 , 155 : 565-8.
39. Tomasulo P. Transfusion alternatives : impact on blood banking worldwide. In Winslow RM, Vandegriff KD, Intaglietta M, eds Advances in blood substitutes. industrial opportunities and medical challenges. Boston Birkhäuser, 1997 : 1-19